Evidence map›Paper›PMID 35490180›Full record

ArticleScientific reports2022

In vivo production of fluorine-18 in a chicken egg tumor model of breast cancer for proton therapy range verification.

Samuel España, Daniel Sánchez-Parcerisa, Paloma Bragado, Álvaro Gutiérrez-Uzquiza, Almudena Porras, Carolina Gutiérrez-Neira, Andrea Espinosa, Víctor V Onecha, Paula Ibáñez, Víctor Sánchez-Tembleque and 2 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.8field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Samuel EspañaGrupo de Física Nuclear and IPARCOS, Facultad de CC. Físicas, Universidad Complutense de Madrid, CEI Moncloa, 28040, Madrid, Spain. sespana@ucm.es.
Daniel Sánchez-ParcerisaGrupo de Física Nuclear and IPARCOS, Facultad de CC. Físicas, Universidad Complutense de Madrid, CEI Moncloa, 28040, Madrid, Spain.
Paloma BragadoInstituto de Investigación Sanitaria del Hospital Clínico San Carlos (IdISSC), Ciudad Universitaria, Madrid, Spain.
Álvaro Gutiérrez-UzquizaInstituto de Investigación Sanitaria del Hospital Clínico San Carlos (IdISSC), Ciudad Universitaria, Madrid, Spain.
Almudena PorrasInstituto de Investigación Sanitaria del Hospital Clínico San Carlos (IdISSC), Ciudad Universitaria, Madrid, Spain.
Carolina Gutiérrez-NeiraGrupo de Física Nuclear and IPARCOS, Facultad de CC. Físicas, Universidad Complutense de Madrid, CEI Moncloa, 28040, Madrid, Spain.
Andrea EspinosaGrupo de Física Nuclear and IPARCOS, Facultad de CC. Físicas, Universidad Complutense de Madrid, CEI Moncloa, 28040, Madrid, Spain.
Víctor V OnechaGrupo de Física Nuclear and IPARCOS, Facultad de CC. Físicas, Universidad Complutense de Madrid, CEI Moncloa, 28040, Madrid, Spain.
Paula IbáñezGrupo de Física Nuclear and IPARCOS, Facultad de CC. Físicas, Universidad Complutense de Madrid, CEI Moncloa, 28040, Madrid, Spain.
Víctor Sánchez-TemblequeGrupo de Física Nuclear and IPARCOS, Facultad de CC. Físicas, Universidad Complutense de Madrid, CEI Moncloa, 28040, Madrid, Spain.
José M UdíasGrupo de Física Nuclear and IPARCOS, Facultad de CC. Físicas, Universidad Complutense de Madrid, CEI Moncloa, 28040, Madrid, Spain.
Luis M FraileGrupo de Física Nuclear and IPARCOS, Facultad de CC. Físicas, Universidad Complutense de Madrid, CEI Moncloa, 28040, Madrid, Spain.
Instituto de Investigación Sanitaria del Hospital Clínico San Carlos · ESUniversidad Complutense de Madrid · ESUniversidad Autónoma de Madrid · ES

Funding

PREVENTION SERVICES TO CHILDREN OF SUBSTANCE ABUSING PARR18DA003888 · NIDA · UNIVERSITY OF UTAH · PI KUMPFER, KAROL L. · 1985 to 1985
–
Marie Curie 793576
6 · The paper itself

Abstract

Range verification of clinical protontherapy systems via positron-emission tomography (PET) is not a mature technology, suffering from two major issues: insufficient signal from low-energy protons in the Bragg peak area and biological washout of PET emitters. The use of contrast agents including

Indexed as

Breast NeoplasmsProton TherapyAnimalsChick EmbryoChickensContrast MediaFemaleFluorine RadioisotopesHumansPositron Emission Tomography Computed TomographyProtonsWaterContrast MediaFluorine-18Fluorine RadioisotopesProtonsWater

Identifiers

PMID35490180
PMCPMC9056503
OpenAlexW4225148279

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.